Adult B Acute Lymphoblastic Leukemia — Trials

Adult B Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: The First Affiliated Hospital of Soochow University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 51–59 of 59 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00873093	Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	completed	Phase 2	148	National Cancer Institute (NCI)NIH	4	Jan 27, 2017	clinicaltrials
NCT02129062	Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia	terminated	Phase 2	3	National Cancer Institute (NCI)NIH	1	Jan 16, 2017	clinicaltrials